Moderna plans more vaccine production for Africa




The U.S. vaccine manufacturer, Moderna, has announced plans to produce mRNA vaccines in .

The firm made the announcement on Thursday, that it will build a drug production plant that can produce, fill and package up to 500 million vaccine doses a year.

Moderna is to invest 500 million dollars in the plant but the site has not yet been selected.

In August, German vaccine maker BioNTech announced it would produce malaria and tuberculosis vaccines in and was looking into setting up production facilities in and Senegal.

Clinical trials for the mRNA vaccines is to begin at the end of 2022.

According to the World Health Organization (), there are also plans for a centre for the production of mRNA vaccines in South with the help of a consortium.

Until now, Africa has had to import the majority of all vaccines. (dpa/)

Be the first to comment

Leave a Reply